Pilot Study Evaluating the Safety and Performance of the GeNO Nitrosyl Delivery System for Inhaled Nitric Oxide
Status: | Archived |
---|---|
Conditions: | High Blood Pressure (Hypertension) |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | Any |
Updated: | 7/1/2011 |
Start Date: | October 2010 |
End Date: | February 2011 |
An Open Label Pilot Study Evaluating Preliminary Safety and Performance of the GeNO Nitrosyl Delivery System
This is an open label phase 2 Pilot study designed to evaluate the safety, tolerability and
device performance of the GeNO nitrosyl delivery system during right heart catheterization
(RHC) in participants with pulmonary arterial hypertension (PAH). All participants will
receive inhaled nitric oxide in oxygen or nitric oxide in air delivered by nasal cannula.
Hemodynamics, clinical laboratory and clinical assessment data will be collected on all
participants to evaluate safety.
We found this trial at
1
site
Click here to add this to my saved trials